Related Experiment Video
Updated: Jun 21, 2026

12:59
A System to Create Stable Nanoparticle Aerosols from Nanopowders
Published on: July 26, 2016
Prednisolone multicomponent nanoparticle preparation by aerosol solvent extraction system.
Kunikazu Moribe1, Mika Fukino, Yuichi Tozuka
1Graduate School of Pharmaceutical Sciences, Chiba University, Inage-ku, Chiba, Japan. moribe@p.chiba-u.ac.jp
International Journal of Pharmaceutics
|July 7, 2009
Summary
The aerosol solvent extraction system (ASES) successfully prepared prednisolone nanoparticles using a ternary mixture. This method is promising for creating drug nanoparticles from multicomponent systems.
Area of Science:
- Materials Science
- Pharmaceutical Technology
Background:
- Nanoparticle drug delivery systems offer enhanced therapeutic efficacy.
- Efficient methods for preparing drug nanoparticles are crucial for pharmaceutical development.
Purpose of the Study:
- To investigate the preparation of prednisolone nanoparticles using the aerosol solvent extraction system (ASES).
- To evaluate the effectiveness of a ternary system involving prednisolone, polyethylene glycol (PEG), and sodium dodecyl sulfate (SDS) for nanoparticle formation.
Main Methods:
- A ternary mixture of prednisolone, PEG, and SDS in methanol was sprayed into supercritical carbon dioxide.
- The aerosol solvent extraction system (ASES) process was optimized and repeated to obtain precipitates.
- Particle size analysis was performed after dispersing the precipitates in water.
Main Results:
- Optimized ASES conditions with a prednisolone/PEG 4000/SDS weight ratio of 1:6:2 yielded prednisolone nanoparticles with a mean size of approximately 230 nm.
- Binary ASES processes (prednisolone with either PEG or SDS alone) did not produce nanoparticles.
- Alternative methods like ternary cryogenic cogrinding and solvent evaporation were ineffective.
Conclusions:
- The aerosol solvent extraction system (ASES) is effective for preparing prednisolone nanoparticles in a multicomponent system.
- The presence of both a hydrophilic polymer (PEG) and a surfactant (SDS) is essential for nanoparticle formation via ASES.
- ASES offers a promising, moderate-temperature approach for manufacturing drug nanoparticles.

